Menu
Recruiting NCT04853173

Modality of Pain Management in Ambulatory Tonsillectomy Surgery in Adults

No phase Interventional Tonsillar Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Assess pain management modalities in adult outpatient tonsillectomy surgery.
Who it may be relevant to
Registry conditions: Tonsillar Disorder. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Modality of Pain Management in Ambulatory Tonsillectomy Surgery in Adults: External Pilot Study

Overview

No SFORL recommendation for adult ambulatory tonsillectomy. This study would allow the establishment of an ambulatory management during an adult tonsillectomy. This would allow a return home from J0 for the patient and therefore would improve the comfort of the patients and reduce the cost associated with a conventional hospitalization over several days.

Interventions

  • Other Assess pain management modalities in adult outpatient tonsillectomy surgery
    use a post-operative analgesia protocol suitable for outpatient surgery. Namely a protocol of analgesia based on the taking of drugs per bone (by mouth) and not intravenous. Pain evaluation.

Primary outcome measures

  • Assess pain management modalities in ambulatory tonsillectomy surgery in adults through post-operative pain assessment, with a defined analgesia and anesthesia protocol adapted to ambulatory management. [Time frame: 14 days]

Eligibility criteria

Inclusion criteria

  • programmed Tonsillectomy surgery

Exclusion criteria

  • Congenital or acquired hemostasis disorder
  • Indication of uvulo-bike-pharyngo-plasty
  • Contraindication to the use of one of the protocol molecules including pregnancy
  • Allergy to analgesic treatments used in the study
  • Ongoing analgesic treatment that cannot be interrupted

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

France · 1 center
  • CHU Besançon — Besançon

Identifiers

NCT: NCT04853173 · 2020/542

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗